Back to News
Market Impact: 0.2
Waters, Labcorp Partner To Expand Access To HPV Screening Test
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Waters Corp. partnered with Labcorp to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp’s laboratory network. The report provides no financial terms or expected revenue impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
LH0.40
WAT0.40
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- Oura sues rival Ultrahuman again, threatening its U.S. smart ring comeback
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)
- AI Portfolio Monitoring: Build an Alert Policy Analysts Can Audit